Neuroone Medical Technologies Revenue Growth Rates (NMTC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Neuroone Medical Technologies Corp  (NASDAQ: NMTC)
 

NMTC's Revenue Growth by Quarter and Year

Neuroone Medical Technologies's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NMTC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter September -
3rd Quarter June -
2nd Quarter March 1.86
1st Quarter December 2.89
FY 4.75

NMTCs Annual Revenue
Neuroone Medical Technologies's Revenue in the fiscal year 2025 $ 9.10 millions
Neuroone Medical Technologies's Revenue in the fiscal year 2023 $ 1.95 millions
Neuroone Medical Technologies's Revenue in the fiscal year 2022 $ 0.17 millions
Neuroone Medical Technologies's Revenue in the fiscal year 2021 $ 0.18 millions
Neuroone Medical Technologies's Revenue in the fiscal year 2015 $ 0.00 millions




NMTC Revenue second quarter 2026 Y/Y Growth Comment
Neuroone Medical Technologies Corp reported Revenue improvement of 33.96% year on year in the second quarter 2026, to $ 1.86 millions, this is lower than Neuroone Medical Technologies Corp's recent average Revenue surge of 237.81%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 93 other companies have achieved higher Revenue growth. While Neuroone Medical Technologies Corp' s Revenue rise of 33.96% ranks overall at the positon no. 1614 in the second quarter 2026.


NMTC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter September - 230.12 % 31.75 % 2000 %
3rd Quarter June - 23.19 % 193.62 % 1075 %
2nd Quarter March 33.96 % 41.84 % 790.91 % 266.67 %
1st Quarter December -11.62 % 341.89 % 957.14 % 40 %
FY   - 131.55 % 207.03 % -

Financial Statements
Neuroone Medical Technologies's second quarter 2026 Revenue $ 1.86 millions NMTC's Income Statement
Neuroone Medical Technologies's second quarter 2025 Revenue $ 1.39 millions Quarterly NMTC's Income Statement


NMTC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter September - 61.18 % -39.86 % 34.04 %
3rd Quarter June - 22.3 % 40.82 % 327.27 %
2nd Quarter March -35.57 % -57.49 % 32.43 % 57.14 %
1st Quarter December 5.47 % 293.98 % 17.46 % 133.33 %
FY (Year on Year)   - 131.55 % 207.03 % -


Back to NMTC Growth rate Comparisons >> Back to NMTC Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #262
Overall #1614

Revenue Y/Y Growth Statistics
High Average Low
1040.65 % 237.81 % -99.48 %
(Sep 30 2023)   (Dec 31 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #262
Overall #1614
Revenue Y/Y Growth Statistics
High Average Low
1040.65 % 237.81 % -99.48 %
(Sep 30 2023)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Neuroone Medical Technologies's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
120450.68 % 7113.81 % -99.93 %
(Sep 30 2021)  


NMTC's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Neuroone Medical Technologies Corp disclosed fall in Revenue from the first quarter by -35.57% to $ 1.86 millions, from $ 2.89 millions achived in the previous reporting period.

But that's not important problem, as Neuroone Medical Technologies's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue quarter on quarter growth. While Neuroone Medical Technologies's Revenue growth quarter on quarter, overall rank is 2737.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #369
Overall #2737
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #369
Overall #2737
Revenue Q/Q Growth Statistics
High Average Low
120450.68 % 7113.81 % -99.93 %
(Sep 30 2021)  


NMTC's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Neuroone Medical Technologies Corp disclosed fall in Revenue from the first quarter by -35.57% to $ 1.86 millions, from $ 2.89 millions achived in the previous reporting period.

But that's not important problem, as Neuroone Medical Technologies's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue quarter on quarter growth. While Neuroone Medical Technologies's Revenue growth quarter on quarter, overall rank is 2737.


Neuroone Medical Technologies's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 9.19 $ 8.72 $ 9.10 $ 7.18 $ 6.86
Y / Y Revenue Growth (TTM) 33.91 % 35.03 % 131.94 % 92.74 % 143.78 %
Year on Year Revenue Growth Overall Ranking # 92 # 4 # 58 # 23 # 9
Seqeuential Revenue Change (TTM) 5.45 % -4.19 % 26.66 % 4.64 % 6.33 %
Seq. Revenue Growth (TTM) Overall Ranking # 1614 # 115 # 1621 # 332 # 196


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Neuroone Medical Technologies's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of 6.33% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Neuroone Medical Technologies's Revenue growth from the 2.89% growth in Dec 31 2025.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 4 to 92.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 35
Overall # 92

Revenue TTM Y/Y Growth Statistics
High Average Low
1040.65 %
 237.81 %
-99.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 262
S&P 500 # 1614
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Neuroone Medical Technologies's cumulative twelve months Revenue were $ 9 millions, company would post below average annual Revenue growth of -99.48% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Neuroone Medical Technologies's Revenue growth from the 2.89% growth in Dec 31 2025.

Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 4 to 92.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 35
Overall # 92

Revenue TTM Y/Y Growth Statistics
High Average Low
1040.65 %
237.81 %
-99.48 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 262
S&P 500 # 1614




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NMTC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Biocorrx Inc 59.04%$ 59.037 millions
Aspira Women s Health inc 58.66%$ 58.656 millions
Hyperfine Inc 58.20%$ 58.205 millions
Macrogenics Inc 57.48%$ 57.482 millions
Axsome Therapeutics Inc 57.42%$ 57.417 millions
Travere Therapeutics Inc 55.63%$ 55.629 millions
Yunhong Green Cti Ltd 55.61%$ 55.613 millions
Eli Lilly And Company55.55%$ 55.549 millions
Kiniksa Pharmaceuticals International Plc55.51%$ 55.507 millions
Kymera Therapeutics Inc 55.50%$ 55.498 millions
Foxo Technologies Inc 51.80%$ 51.803 millions
Lucid Diagnostics Inc 51.69%$ 51.691 millions
Carlsmed Inc 51.39%$ 51.389 millions
Camp4 Therapeutics Corporation50.82%$ 50.816 millions
Guardant Health Inc 48.26%$ 48.259 millions
Sonoma Pharmaceuticals Inc 48.14%$ 48.135 millions
Verrica Pharmaceuticals Inc 46.06%$ 46.060 millions
Intelligent Bio Solutions Inc 45.54%$ 45.541 millions
Establishment Labs Holdings Inc 45.40%$ 45.400 millions
Iovance Biotherapeutics inc 44.82%$ 44.818 millions
Mirum Pharmaceuticals Inc 43.28%$ 43.283 millions
Clearpoint Neuro Inc 42.93%$ 42.935 millions
Biodesix Inc 42.30%$ 42.304 millions
Neurocrine Biosciences Inc 42.25%$ 42.246 millions
Halozyme Therapeutics Inc 42.23%$ 42.229 millions
Zevra Therapeutics Inc 42.17%$ 42.170 millions
Omada Health Inc 41.36%$ 41.355 millions
Glaukos Corp41.26%$ 41.265 millions
The Oncology Institute Inc 41.22%$ 41.219 millions
Eton Pharmaceuticals Inc 40.77%$ 40.769 millions


About Neuroone Medical Technologies Revenue Growth Rates (NMTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Neuroone Medical Technologies Corp (CIK 1500198).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-088724
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Neuroone Medical Technologies Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.